StockNews.com Begins Coverage on Forward Pharma A/S (NASDAQ:FWP)

StockNews.com began coverage on shares of Forward Pharma A/S (NASDAQ:FWPGet Rating) in a report released on Monday. The brokerage issued a sell rating on the biotechnology company’s stock.

Forward Pharma A/S Price Performance

Shares of Forward Pharma A/S stock opened at $3.00 on Monday. Forward Pharma A/S has a 12 month low of $2.81 and a 12 month high of $7.20. The business has a fifty day simple moving average of $3.05 and a 200 day simple moving average of $3.89.

About Forward Pharma A/S

(Get Rating)

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Recommended Stories

Receive News & Ratings for Forward Pharma A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forward Pharma A/S and related companies with MarketBeat.com's FREE daily email newsletter.